ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Cannabist Company Holdings Inc

Cannabist Company Holdings Inc (CBST)

0,11
-0,015
(-12,00%)
Fermé 12 Décembre 10:00PM
Données en temps réel

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,11
Prix Achat
0,11
Prix Vente
0,12
Volume échangé
435 169
0,11 Fourchette du Jour 0,13
0,11 Plage de 52 semaines 0,83
Clôture Veille
0,125
Ouverture
0,13
Dernière Transaction
2000
@
0.11
Dernière heure de transaction
Volume moyen (3 m)
513 482
Volume financier
-
VWAP
-

CBST Dernières nouvelles

Verano Announces Closing of Acquisition of Arizona and Virginia Subsidiaries of The Cannabist Company, Becomes Exclusive Cannabis Operator for HSA 5 in Eastern Virginia and Strengthens Arizona Footprint

Acquisitions Expand Verano’s Footprint to 14 States, 15 Cultivation and Production Facilities, and 150 Dispensaries Nationwide CHICAGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp...

Dana Holding Set to Join the S&P MidCap 400

Dana Holding Set to Join the S&P MidCap 400 PR Newswire NEW YORK, Jan. 20, 2015 NEW YORK, Jan. 20, 2015 /PRNewswire/ -- Dana Holding Corp. (NYSE: DAN) will replace Cubist Pharmaceuticals Inc...

Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated...

Cubist meldet FDA-Zulassung seines neuen Antibiotikums ZERBAXA™ (Ceftolozan/Tazobactam) für komplizierte Harnwegsinfektion...

ZERBAXA geht bestimmte gefährliche und resistente gramnegative Bakterien anErstes in den USA unter dem GAIN-Gesetz zugelassenes Antibiotikum gegen gramnegative Bakterien Cubist...

Cubist annonce l’approbation par la FDA du nouvel antibiotique ZERBAXA™ (ceftolozane/tazobactam) pour le traitement des i...

ZERBAXA s’attaque à certaines bactéries à Gram négatif graves et résistantes Premier nouvel antibiotique approuvé aux États-Unis dans le cadre de la GAIN Act pour le traitement des...

Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract & Complicat...

ZERBAXA addresses certain serious and resistant Gram-negative bacteriaFirst new antibiotic approved in U.S. under the GAIN Act that treats Gram-negative bacteria Cubist...

Merck Begins Tender Offer to Acquire Cubist

Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. R...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company PR Newswire BALA...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over ...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc...

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourag...

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.035-24.13793103450.1450.1550.113032630.13156425CS
4-0.04-26.66666666670.150.1850.115152450.15352846CS
12-0.195-63.93442622950.3050.3550.115134820.20869547CS
26-0.18-62.06896551720.290.420.114954260.26207871CS
52-0.49-81.66666666670.60.830.119863570.45669899CS
156-1.57-93.45238095241.681.760.1110708880.56071542CS
260-1.57-93.45238095241.681.760.1110708880.56071542CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTQBTQ Technologies Corp
$ 2,85
(88,74%)
6,36M
IFSSInterfield Global Software Inc
$ 0,07
(27,27%)
1 000
IBERIberAmerican Lithium Corp
$ 0,05
(25,00%)
110,5k
HOLDImmutable Holdings Inc
$ 0,13
(13,04%)
12,6k
SUNNSolarBank Corporation
$ 3,30
(10,74%)
5,4k
CDMNCanadian Manganese Company Inc
$ 0,05
(-28,57%)
923,82k
DMETDenarius Metals Corp
$ 0,58
(-17,14%)
67,5k
MLMMcfarlane Lake Mining Limited
$ 0,025
(-16,67%)
1,02M
LITSLithos Energy Ltd
$ 0,035
(-12,50%)
662,5k
FHFilament Health Corp
$ 0,035
(-12,50%)
291,08k
BTQBTQ Technologies Corp
$ 2,85
(88,74%)
6,36M
DEFIValour Inc
$ 4,71
(4,90%)
1,18M
VERSVerses AI Inc
$ 0,465
(6,90%)
1,05M
MLMMcfarlane Lake Mining Limited
$ 0,025
(-16,67%)
1,02M
CDMNCanadian Manganese Company Inc
$ 0,05
(-28,57%)
923,82k
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock